Clinical and physiological correlates of caffeine and caffeine metabolites in primary insomnia

Journal of Clinical Sleep Medicine

Volumn 7, Issue 2, 2011, Pages 196-203

  Youngberg, Mark R ^a   Karpov, Irina O ^a   Begley, Amy ^a   Pollock, Bruce G ^a   Buysse, Daniel J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Caffeine; Insomnia; Metabolite; Paraxanthine; Xanthine

Indexed keywords

CAFFEINE; CAFFEINE DERIVATIVE; PARAXANTHINE;

ADULT; ARTICLE; BLOOD SAMPLING; COFFEE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; SLEEP PARAMETERS; SLEEP QUALITY;

EID: 79958014544     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.28109     Document Type: Article

References (44)

1. nd ed.: diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine, 2005.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. Washington, DC: American Psychiatric Association, 1994.
3. Ohayon MM. Epidemiology of insomnia: What we know and what we still need to learn. Sleep Med Rev 2002;6:97-111.
4. Frary CD, Johnson RK, Wang MQ. Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc 2005;105:110-13.
5. Kaplan GB, Greenblatt DJ, Ehrenberg BL, et al. Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol 1997;37:693-703. (Pubitemid 27449278)
6. Haskell CF, Kennedy DO, Wesnes KA, et al. Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine. Psychopharmacology 2005;179:813-25. (Pubitemid 40767901)
7. Wyatt JK, Cajochen C, Ritz-De Cecco A, et al. Low-dose repeated caffeine administration for circadian-phase-dependent performance degradation during extended wakefulness. Sleep 2004;27:374-81. (Pubitemid 44138795)
8. Fredholm BB, Lindstrom K. Autoradiographic comparison of the potency of several structurally unrelated adenosine receptor antagonists at adenosine A1 and A(2A) receptors. Eur J Pharmacol 1999;380:197-202. (Pubitemid 29469530)
9. Benington JH, Heller HC. Restoration of brain energy-metabolism as the function of sleep. Prog Neurobiol 1995;45:347-60.
10. Karacan I, Thornby JI, Anch M, et al. Dose-related sleep disturbances induced by coffee and caffeine. Clin Pharmacol Ther 1976;20:682-89. (Pubitemid 8020948)
11. Bonnet MH, Arand DL. Caffeine use as a model of acute and chronic insomnia. Sleep 1992;15:526-36.
12. Paterson LM, Wilson SJ, Nutt DJ, et al. A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers. Psychopharmacology 2007;191:943-50. (Pubitemid 46399141)
13. Landolt HP, Dijk DJ, Gaus SE, et al. Caffeine reduces low-frequency delta activity in the human sleep EEG. Neuropsychopharmacology 1995;12:229-38.
14. Landolt HP, Retey JV, Tonz K, et al. Caffeine attenuates waking and sleep electroencephalographic markers of sleep homeostasis in humans. Neuropsychopharmacology 2004;29:1933-9. (Pubitemid 39336805)
15. Landolt HP, Werth E, Borbely AA, et al. Caffeine intake (200 mg) in the morning affects human sleep and EEG power spectra at night. Brain Res 1995;675:67-74.
16. Sanchez-Ortuno M, Moore N, Taillard J, et al. Sleep duration and caffeine consumption in a French middle-aged working population. Sleep Med 2005;6:247-51. (Pubitemid 40613535)
17. Ohayon MM, Caulet M, Philip P, et al. How sleep and mental disorders are related to complaints of daytime sleepiness. Arch Intern Med 1997;157:2645-52. (Pubitemid 27519985)
18. Hughes JR, Hale KL. Behavioral effects of caffeine and other methylxanthines on children. Exp Clin Psychopharmacol 1998;6:87-95. (Pubitemid 28102889)
19. Giannotti F, Cortesi F, Sebastiani T, et al. Circadian preference, sleep and daytime behaviour in adolescence. J Sleep Res 2002;11:191-9. (Pubitemid 35014003)
20. Bonnet MH, Arand DL. Situational insomnia: consistency, predictors, and outcomes. Sleep 2003;26:1029-36. (Pubitemid 39619766)
21. Drake CL, Jefferson C, Roehrs T, et al. Stress-related sleep disturbance and polysomnographic response to caffeine. Sleep Med 2006;7:567-72. (Pubitemid 44480748)
22. Luciano M, Zhu G, Kirk KM, et al. "No thanks, it keeps me awake": the genetics of coffee-attributed sleep disturbance. Sleep 2007;30:1378-86. (Pubitemid 47548289)
23. Retey JV, Adam M, Khatami R, et al. A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep. Clin Pharmacol Ther 2007;81:692-98. (Pubitemid 46625104)
24. Hauri P. Case studies in insomnia. xiv ed. New York: Plenum Medical Book Co., 1991.
25. Buysse DJ, Germain A, Hall ML, et al. EEG spectral analysis in primary insomnia: NREM period effects and sex differences. Sleep 2008;31:1673-82.
26. First MB, Gibbon M, Spitzer RL, et al. Structured Clinical Interview for DSM-IV Axis I Disorders SCID I: Clinician version, administration booklet. Washington, D.C.: American Psychiatric Press, 1997.
27. Monk TH, Reynolds CF, Kupfer DJ, et al. The Pittsburgh Sleep Diary. J Sleep Res 1994;3:111-20. (Pubitemid 24173501)
28. Buysse DJ, Thompson W, Scott J, et al. Daytime symptoms in primary insomnia: A prospective analysis using ecological momentary assessment. Sleep Med 2007;8:198-208. (Pubitemid 46488861)
29. Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213. (Pubitemid 19144991)
30. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
31. Roehrs T, Roth T. Caffeine: sleep and daytime sleepiness. Sleep Med Rev 2008;12:153-62. (Pubitemid 351374841)
32. Hughes JR, Oliveto AH. A systematic survey of caffeine intake in Vermont. Exp Clin Psychopharmacol 1997;5:393-8. (Pubitemid 27490386)
33. Doman J, Detka C, Hoffman T, et al. Automating the sleep laboratory: Implementation and validation of digital recording and analysis. Int J Biomed Comput 1995;38:277-90.
34. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. NIH Publication 204. Washington, DC: U.S. Government Printing Office, Department of Health Education and Welfare, 1968.
35. Vasko RC, Brunner DP, Monahan JP, et al. Power spectral analysis of EEG in a multiple-bedroom, multiple-polygraph sleep laboratory. Int J Med Inform 1997;46:175-84. (Pubitemid 27478133)
36. Brunner DP, Vasko RC, Detka CS, et al. Muscle artifacts in the sleep EEG: Automated detection and effect on all-night EEG power spectra. J Sleep Res 1996;5:155-64. (Pubitemid 26380244)
37. Benowitz NL, Jacob P III, Mayan H, et al. Sympathomimetic effects of paraxanthine and caffeine in humans. Clin Pharmacol Ther 1995;58:684-91. (Pubitemid 26018853)
38. Lelo A, Kjellen G, Birkett DJ, et al. Paraxanthine metabolism in humans: determination of metabolic partial clearances and effects of allopurinol and cimetidine. J Pharmacol Exp Ther 1989;248:315-9. (Pubitemid 19063507)
39. Denaro CP, Brown CR, Wilson M, et al. Dose-dependency of caffeine metabolism with repeated dosing. Clin Pharmacol Ther 1990;48:277-85. (Pubitemid 20323654)
40. Bunker ML, McWilliams M. Caffeine content of common beverages. J Am Diet Assoc 1979;74:28-32.
41. Nicholson AN, Stone BM. Heterocyclic amphetamine derivatives and caffeine on sleep in man. Br J Clin Pharmacol 1980;9:195-203. (Pubitemid 10183142)
42. Ohayon MM, Lemoine P. [Sleep and insomnia markers in the general population]. Encephale 2004;30:135-140.
43. Lovallo WR, Whitsett TL, Al'Absi M, et al. Caffeine stimulation of cortisol secretion across the waking hours in relation to caffeine intake levels. Psychosom Med 2005;67:734-9. (Pubitemid 41396019)
44. Lovallo WR, Wilson MF, Vincent AS, et al. Blood pressure response to caffeine shows incomplete tolerance after short-term regular consumption. Hypertension 2004;43:760-5. (Pubitemid 38405583)